文献速递肾移植

肾移植受者意义未明单克隆丙种球蛋白病的长期结局

Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

在法国两中心3059例肾移植受者中,识别移植时存在MGUS者70例及移植后发生MGUS者114例,并将移植时MGUS与匹配对照比较。移植时MGUS与更高的移植后实体癌发生频率及更早出现相关,细菌感染有增多趋势,但患者和移植物生存、排斥反应及血液学并发症无差异。移植时MGUS不应成为肾移植禁忌,但需延长监测。

要点

  • 移植时MGUS与匹配对照在患者生存、移植物生存、排斥反应及血液学并发症方面无差异。
  • 移植时血清游离轻链异常和/或严重低丙种球蛋白血症者总生存期更短。

核心结论

  • 移植时检测到MGUS与移植物排斥反应发生率升高无关,也不对移植物生存或总生存产生不利影响。
  • MGUS不应成为肾移植的禁忌证。
  • 移植时MGUS可能与早期肿瘤和感染并发症风险较高相关,需要延长监测。

研究设计与样本

  • 在法国两个肾移植中心3059例接受肾移植的患者中,识别出移植时存在MGUS的受者70例(KTMG)和移植后发生MGUS的患者114例(DNMG)。
  • 将KTMG患者与无MGUS的匹配对照进行比较。

主要发现

  • KTMG与匹配对照在患者生存、移植物生存、排斥反应及血液学并发症方面无差异。
  • 移植时kappa/lambda比值异常和/或严重低丙种球蛋白血症的KTMG患者总生存期更短。

临床怎么用

  • 移植时MGUS不应作为肾移植的禁忌证。
  • 移植时MGUS患者可能需要延长肿瘤和感染并发症的监测。
  • 移植前应检测血清游离轻链,以细化KTMG患者的风险评估并制定个体化随访和免疫抑制方案。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Because of increased access to kidney transplantation in elderly subjects, the prevalence of monoclonal gammopathies of unknown significance (MGUS) in kidney transplantation (KT) is growing. However, little is known about the consequences of MGUS on long-term outcomes. METHODS: We identified 70 recipients with MGUS present at transplantation (KTMG) and 114 patients with MGUS occurring after KT (DNMG), among 3059 patients who underwent a KT in two French kidney transplantation centers. We compared outcomes of KTMG with those of matched controls. RESULTS: Baseline characteristics were similar except for an older age in KTMG compared with the DNMG group (62 vs 57 years, P = .03). Transient MGUS occurred more frequently in DNMG patients (45% vs 24%, P = .007). When compared with matched controls without MGUS, KTMG patients showed higher frequency and earlier post-transplant solid cancers (15% vs 5%, P = .04) and a trend for more bacterial infections (63% vs 48%, P = .08), without difference regarding patient and graft survival, rejection episodes or hematological complications. KTMG patients with an abnormal kappa/lambda ratio and/or severe hypogammaglobulinemia at the time of KT experienced shorter overall survival. CONCLUSIONS: MGUS detection at the time of KT is neither associated with a higher occurrence of graft rejection, nor adversely affects graft or overall survival. MGUS should not contraindicate KT. However, MGUS at the time of KT may be associated with higher risk of early neoplastic and infectious complications and warrants prolonged surveillance. Measurement of serum free light chain should be performed before transplant to refine the risk evaluation of KTMG patients and propose personalized follow-up and immunosuppression.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Meuleman MS, Mouyabi S, Gueguen J, et al. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes. Nephrol Dial Transplant. 2023. PMID: 37403344. doi:10.1093/ndt/gfad144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。